( 02696.hk)
市盈率35.20市净率8.34股息率0%上市时间2019-09-25股价57.30港币涨跌幅-0.87%成交金额3,594.48万港币换手率0.12%市值311.42亿港币H股市值93.64亿港币总股本5.43亿H股本1.63亿每手股数100上市至今年化投资收益率2.51%累计做空占H股比例1.06% (1.01亿港币2026-01-23)
所属三级行业生物技术 (恒生) 市盈率66.68市净率5.06股息率0.31%恒生:医疗保健业药品及生物科技生物技术
备注 (1): 双击编辑备注
发表讨论

复宏汉霖(02696) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1WANG Xing LiNon Executive Director2023-08-28--
2朱俊Executive DirectorCEO2023-08-28--
3文德鏞Non Executive Director2022-07-28--
4張文傑Executive DirectorChairman2020-09-30--
5晏子厚Non Executive Director2020-02-192023-07-17
6陳力元Independent Non Executive Director2019-09-02--
7蘇德揚Independent Non Executive Director2019-09-02--
8宋瑞霖Independent Non Executive Director2019-09-02--
9趙國屏Independent Non Executive Director2019-09-02--
10關曉暉Non Executive Director2018-12-24--
11HUI AiminNon Executive Director2018-04-102022-07-28
12吳以芳Non Executive Director2015-06-12--
13陳啟宇Non Executive Director2013-01-15--
14LIU Shi Kau ScottExecutive Director2013-01-152020-09-30
15傅潔民Non Executive Director2013-01-152019-12-24